GLORIA PERRY: Open Payments
NPI 1417459611 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,421 in 171 payments from 31 companies in 2025. Trend: 2023 $21 · 2024 $245 · 2025 $3,421
Food & beverage: $3,344Education: $76
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $712 |
| Teva Pharmaceuticals USA, Inc. | 28 | $379 |
| UCB, Inc. | 11 | $233 |
| ARGENX US, INC. | 9 | $209 |
| Lundbeck LLC | 11 | $194 |
| PFIZER INC. | 11 | $187 |
| Otsuka America Pharmaceutical, Inc. | 13 | $184 |
| Eisai Inc. | 8 | $155 |
| Medtronic, Inc. | 2 | $155 |
| Biogen, Inc. | 5 | $120 |
Products named: UBRELVY, AUSTEDO XR, REXULTI, VYVGART, NURTEC ODT, Leqembi, QULIPTA, VENASEAL.
Industry payments across CA — which companies pay providers there.
